NCT03490240Active, not recruiting
Project BIPAMS: Behavioral Intervention for Physical Activity in Multiple Sclerosis
Source: ClinicalTrials.gov · Last updated 22 Dec 2025
Brief summary (registry, in English)
This randomized controlled trial will examine the effect of a 6-month behavioral intervention, based on social cognitive theory and delivered through the Internet, for increasing physical activity and secondarily improving mobility, cognition, symptoms and quality of life in persons with MS. The investigators hypothesize that individuals who receive the 6-month behavioral intervention will demonstrate an increase in physical activity behavior that will last throughout a 6-month follow up compared with participants in the control condition. The investigators further hypothesize that individuals in the behavioral intervention will demonstrate better walking mobility and cognitive function, reduced fatigue, depression, anxiety, and pain, and improved quality of life compared to the control condition. The investigators hypothesize that the behavioral intervention will increase physical activity through positive changes in self-efficacy, outcome expectations, goal setting, and impediments as social-cognitive determinants.
- Status (registry)
- Active, not recruiting
- Study type
- Interventional
- Enrollment
- 280 (estimated)
- First submitted
- 23 Jan 2018
- Start date
- 1 Mar 2018
- Primary completion date
- 1 Mar 2023
- Lead sponsor
- University of Alabama at Birmingham
- Diseases
- Multiple sclerosis
- NCT number
- NCT03490240
What you commit to
- Study type: Interventional
- Planned participants: 280
- From 1 Mar 2018 to the primary completion date, 1 Mar 2023
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- Moderate or high risk for undertaking strenuous or maximal exercise per participants response to the PAR-Q. Those who report no more than one YES or affirmative on the 7 item PAR-Q will be considered at low risk and included for participation. All others will be considered at moderate or high risk and excluded from participation.
Who the study is looking for
- Diagnosis of MS
- Relapse free in the past 30 days
- Internet and email access
- Willingness to complete the questionnaires, wear the accelerometer, and undergo randomization
- Being non-active defined as not engaging in regular activity (30 minutes accumulated per day) on more than 2 days of the week during the previous six months
- Ability to ambulate with or without assistance (i.e. walking with or without a can or walker, but not a wheelchair)
- Age between 18 and 64
Age in the registry: 18 years to 64 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Exercise Neuroscience Research Lab Coordinator of this site? Confirm its status | Birmingham | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.